Valuation: Pharmaids Pharmaceuticals Limited

Market Cap 98Cr 1.03Cr 91.95L 84.83L 76.77L 1.44Cr 1.46Cr 10Cr 4.04Cr 51Cr 3.85Cr 3.77Cr 162.05Cr P/E 2025
-22.5x
P/E 2026 -8.33x
Enterprise Value 124.17Cr 1.3Cr 1.17Cr 1.08Cr 97.5L 1.82Cr 1.85Cr 13Cr 5.13Cr 65Cr 4.89Cr 4.79Cr 205.82Cr EV / Sales 2025
14.5x
EV / Sales 2026 4.45x
Free-Float
25.69%
Yield 2025 *
-
Yield 2026 -
12/08 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
29/05 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
12/02 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
05/01 Pharmaids Pharmaceuticals Limited Announces Completion of Term of Mopperthy Sudheer as Independent Director and Member of the Audit Committee and Nomination & Remuneration Committee, Effective January 5, 2026 CI
02/01 Pharmaids Pharmaceuticals Limited Appoints Dr. Yogananda Moolemath as Independent Director, Effective January 1, 2026 CI
28/11 Pharmaids Pharmaceuticals appoints P N Vijay as chairman effective December 5, 2025 RE
28/11 Pharmaids Pharmaceuticals Limited Announces Board and Committee Changes CI
11/11 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
18/25/18 Sourabh Hadimani completed the acquisition of 66.50% stake in Anugraha Chemicals P. Ltd. from Pharmaids Pharmaceuticals Limited. CI
18/25/18 Shankarappa Nagaraja Vinaya Babu completed the acquisition of 7.68% stake in Pharmaids Pharmaceuticals Limited for approximately INR 170 million. CI
07/25/07 Pharmaids Pharmaceuticals Limited Announces Executive Changes, Effective August 7, 2025 CI
07/25/07 Pharmaids Pharmaceuticals Limited Announces Resignation of S Prasad as the Chief Executive Officer Effective August 07, 2025 CI
07/25/07 Pharmaids Pharmaceuticals CEO S Prasad resigns RE
1 day-2.46%
1 week-4.15%
Current month-5.71%
1 month-5.71%
3 months-9.94%
6 months-6.57%
Current year-41.84%
1 week 27.31
Extreme 27.31
31.9
1 month 27
Extreme 27
32.5
Current year 25.6
Extreme 25.6
50.9
1 year 25.6
Extreme 25.6
53.9
3 years 25.6
Extreme 25.6
87.46
5 years 10.17
Extreme 10.17
87.46
10 years 2.15
Extreme 2.15
87.46
Manager TitleAgeSince
Director of Finance/CFO - 13/10/2022
Chief Tech/Sci/R&D Officer - 07/08/2025
Compliance Officer - 14/08/2024
Director TitleAgeSince
Director/Board Member - 09/07/2022
Director/Board Member - -
Chairman 75 05/12/2025
Change 5-day change 1-year change 3-year change Capi.($)
-2.46%-4.15%-44.68%-41.02% 1.05Cr
+4.09%+12.44%+69.55%+153.10% 1,22400Cr
+0.95%+5.89%+47.77%+90.00% 66TCr
+1.45%+4.19%+30.42%+109.75% 51TCr
+0.16%+3.38%+54.41%+67.47% 39TCr
+1.98%+3.75%+74.68%+46.78% 36TCr
+1.35%+5.27%+36.27%+59.21% 30TCr
+6.08%+8.84%+11.25%+36.60% 27TCr
+2.18%+7.88%+62.29%+80.05% 25TCr
+4.09%+10.36%+45.39%+121.43% 21TCr
Average +2.04%+2.38%+38.74%+72.34% 41.77TCr
Weighted average by Cap. +2.59%+3.04%+52.51%+100.35%

Financials

2025 2026
Net sales 19Cr 20.42L 18.29L 16.88L 15.27L 28.56L 29.02L 2.01Cr 80.32L 10Cr 76.64L 75.01L 32Cr 28Cr 29.28L 26.23L 24.2L 21.89L 40.94L 41.6L 2.89Cr 1.15Cr 15Cr 1.1Cr 1.08Cr 46Cr
Net income -11Cr -11.32L -10.14L -9L -8L -15.82L -16.08L -1.12Cr -44.51L -5.64Cr -42.47L -41.57L -18Cr -12Cr -12.3L -11.02L -10.17L -9L -17.2L -17.48L -1.21Cr -48.39L -6.13Cr -46.18L -45.19L -19Cr
Net Debt 40Cr 41.88L 37.51L 34.61L 31.32L 58.56L 59.51L 4.13Cr 1.65Cr 21Cr 1.57Cr 1.54Cr 66Cr 26Cr 27.73L 24.84L 22.91L 20.73L 38.77L 39.4L 2.73Cr 1.09Cr 14Cr 1.04Cr 1.02Cr 44Cr
Projected Income Statement - Annual - Pharmaids Pharmaceuticals Limited
Logo Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The Company operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.
Employees
127
Date Price Change Volume
30/26/30 ₹27.72 -2.46% 3,285
29/26/29 ₹28.42 +3.27% 2,010
28/26/28 ₹27.52 -4.38% 3,865
27/26/27 ₹28.78 +0.95% 1,483
26/26/26 ₹28.51 -1.42% 2,387
  1. Stock Market
  2. Stocks
  3. PHARMAID Stock